NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

CompletedN/A

Sponsor: Sanofi Pasteur, a Sanofi Company

Conditions: Yellow Fever

Interventions: Stamaril®

Countries: South Korea

This is a passive enhance safety surveillance (ESS) of Stamaril® vaccine in Korea. The objective is to collect suspected related adverse events following vaccination with Stamaril® in routine practice.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Vaccination with Stamaril® vaccine in routine practice in Korea

Locations (1)

Seoul, South Korea